Drug information for THYROGEN
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INJECTION
1.1MG/VIAL
Prescription
(Reference Drug)
THYROTROPIN ALFA
Glycoprotein Hormones, alpha Subunit
GENZYME
20898
2008-08-29 Label
2008-08-19 Letter
2008-01-09 Letter
2007-12-27 Label
2006-01-30 Letter
2006-01-25 Label
2004-04-05 Label
2004-03-16 Letter
2001-06-19 Review
1998-11-30 Label
1998-11-30 Letter
Drug Adverse Effects information for THYROGEN
Role code
Indications
Reaction
# Reports
PS
DIAGNOSTIC PROCEDURE
DECREASED APPETITE
1
PS
DIAGNOSTIC PROCEDURE
HYPOACUSIS
1
PS
DIAGNOSTIC PROCEDURE
MOBILITY DECREASED
1
PS
DIAGNOSTIC PROCEDURE
NAUSEA
1
PS
DIAGNOSTIC PROCEDURE
SPEECH DISORDER
1
PS
DIAGNOSTIC PROCEDURE
VISUAL IMPAIRMENT
1
PS
DIAGNOSTIC PROCEDURE
VOMITING
1
PS
DIAGNOSTIC PROCEDURE
WHITE BLOOD CELL DISORDER
1
PS
THYROID CANCER
ANAEMIA
1
PS
THYROID CANCER
DECREASED APPETITE
1
PS
THYROID CANCER
DYSPNOEA
2
PS
THYROID CANCER
HEARING IMPAIRED
1
PS
THYROID CANCER
LUNG CONSOLIDATION
2
PS
THYROID CANCER
MOVEMENT DISORDER
1
PS
THYROID CANCER
NAUSEA
1
PS
THYROID CANCER
OXYGEN SATURATION DECREASED
2
PS
THYROID CANCER
PAIN
2
PS
THYROID CANCER
SPEECH DISORDER
1
PS
THYROID CANCER
STRIDOR
2
PS
THYROID CANCER
TRACHEAL DISORDER
2
PS
THYROID CANCER
VISUAL ACUITY REDUCED
1
PS
THYROID CANCER
VOMITING
1
PS
THYROID CANCER
WHITE BLOOD CELL COUNT ABNORMAL
1
Ads by Google